Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -2,230 | -1,880 | -1,060 | -500 |
| Depreciation Amortization | 170 | 80 | 30 | 20 |
| Other Operating Activity | -580 | 60 | 40 | 180 |
| Operating Cash Flow | $-2,640 | $-1,740 | $-990 | $-300 |
| Cash Flows From Investing Activities | ||||
| Other Investing Activity | -1,860 | -350 | -250 | -30 |
| Investing Cash Flow | $-1,860 | $-350 | $-250 | $-30 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 14,040 | 1,480 | 1,240 | 930 |
| Financing Cash Flow | $14,040 | $1,480 | $1,240 | $930 |
| Beginning Cash Position | 30 | 640 | 640 | 50 |
| End Cash Position | 9,570 | 30 | 640 | 640 |
| Net Cash Flow | $9,530 | $-600 | $-4 | $590 |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,640 | -1,740 | -990 | -300 |
| Free Cash Flow | -2,640 | -1,740 | -990 | -300 |